WCN26-3934 A CASE OF LYSOZYME-INDUCED NEPHROPATHY ASSOCIATED WITH MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASM (MDS/MPN)

Read full text Summarise with VIRAT
Authors: Norihiro Nukui, Ei Kusahana, Tatuhiko Azegami, Kaori Hayashi, Akinori Hashiguchi, Hirobumi Tokuyama
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Lysozyme is a protein that hydrolyzes bacterial peptidoglycans and is produced by neutrophils, monocytes, and macrophages. It is filtered through the glomeruli, reabsorbed by proximal tubular cells, and degraded within lysosomes. Lysozyme-induced nephropathy is a kidney disorder caused by proximal tubular injury secondary to excessive lysozyme production in diseases such as myeloid malignancies and sarcoidosis. We present a case of chronic kidney disease initially suspected to be diabetic nephropathy, later identified as lysozyme-induced nephropathy secondary to a myelodysplastic/myeloproliferative neoplasm (MDS/MPN).Treatment for the underlying hematologic malignancy successfully prevented progression to dialysis.

Fields of Study & Subjects

Renal Diseases and Glomerulopathies Multiple Myeloma Research and Treatments Chronic Kidney Disease and Diabetes

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104329–104329
Publication date
25 March 2026
Language
EN